These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 15863619)

  • 1. Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease.
    Tao Y; Kim J; Faubel S; Wu JC; Falk SA; Schrier RW; Edelstein CL
    Proc Natl Acad Sci U S A; 2005 May; 102(19):6954-9. PubMed ID: 15863619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease.
    Tao Y; Kim J; Schrier RW; Edelstein CL
    J Am Soc Nephrol; 2005 Jan; 16(1):46-51. PubMed ID: 15563559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An mTOR kinase inhibitor slows disease progression in a rat model of polycystic kidney disease.
    Ravichandran K; Zafar I; Ozkok A; Edelstein CL
    Nephrol Dial Transplant; 2015 Jan; 30(1):45-53. PubMed ID: 25239638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caspases, Bcl-2 proteins and apoptosis in autosomal-dominant polycystic kidney disease.
    Ecder T; Melnikov VY; Stanley M; Korular D; Lucia MS; Schrier RW; Edelstein CL
    Kidney Int; 2002 Apr; 61(4):1220-30. PubMed ID: 11918728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of sodium-glucose cotransporters with phlorizin inhibits polycystic kidney disease progression in Han:SPRD rats.
    Wang X; Zhang S; Liu Y; Spichtig D; Kapoor S; Koepsell H; Mohebbi N; Segerer S; Serra AL; Rodriguez D; Devuyst O; Mei C; Wüthrich RP
    Kidney Int; 2013 Nov; 84(5):962-8. PubMed ID: 23715121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N; Ogbori MR; Nicman E
    Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
    Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
    Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A new in vitro bioassay for cyst formation by renal cells from an autosomal dominant rat model of polycystic kidney disease.
    Pey R; Bach J; Schieren G; Gretz N; Hafner M
    In Vitro Cell Dev Biol Anim; 1999; 35(10):571-9. PubMed ID: 10614866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of paclitaxel on the progression of polycystic kidney disease in rodents.
    Martinez JR; Cowley BD; Gattone VH; Nagao S; Yamaguchi T; Kaneta S; Takahashi H; Grantham JJ
    Am J Kidney Dis; 1997 Mar; 29(3):435-44. PubMed ID: 9041221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. mTORC1/2 and rapamycin in female Han:SPRD rats with polycystic kidney disease.
    Belibi F; Ravichandran K; Zafar I; He Z; Edelstein CL
    Am J Physiol Renal Physiol; 2011 Jan; 300(1):F236-44. PubMed ID: 20943770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathways of caspase-mediated apoptosis in autosomal-dominant polycystic kidney disease (ADPKD).
    Tao Y; Kim J; Stanley M; He Z; Faubel S; Schrier RW; Edelstein CL
    Kidney Int; 2005 Mar; 67(3):909-19. PubMed ID: 15698430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered ATP-sensitive P2 receptor subtype expression in the Han:SPRD cy/+ rat, a model of autosomal dominant polycystic kidney disease.
    Turner CM; Ramesh B; Srai SK; Burnstock G; Unwin RJ
    Cells Tissues Organs; 2004; 178(3):168-79. PubMed ID: 15655334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor κB-induced inflammation.
    Wu M; Gu J; Mei S; Xu D; Jing Y; Yao Q; Chen M; Yang M; Chen S; Yang B; Qi N; Hu H; Wüthrich RP; Mei C
    Nephrol Dial Transplant; 2016 Nov; 31(11):1826-1834. PubMed ID: 27190325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Androgen receptor pathway in rats with autosomal dominant polycystic kidney disease.
    Nagao S; Kusaka M; Nishii K; Marunouchi T; Kurahashi H; Takahashi H; Grantham J
    J Am Soc Nephrol; 2005 Jul; 16(7):2052-62. PubMed ID: 15888569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of Aerobic Glycolysis Attenuates Disease Progression in Polycystic Kidney Disease.
    Riwanto M; Kapoor S; Rodriguez D; Edenhofer I; Segerer S; Wüthrich RP
    PLoS One; 2016; 11(1):e0146654. PubMed ID: 26752072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of lovastatin on the development of polycystic kidney disease in the Han:SPRD rat.
    Gile RD; Cowley BD; Gattone VH; O'Donnell MP; Swan SK; Grantham JJ
    Am J Kidney Dis; 1995 Sep; 26(3):501-7. PubMed ID: 7645559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats.
    Cowley BD; Rupp JC; Muessel MJ; Gattone VH
    Am J Kidney Dis; 1997 Feb; 29(2):265-72. PubMed ID: 9016899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of [¹⁸F]PFH PET renography to predict future disease progression in a rat model of autosomal dominant polycystic kidney disease.
    Pathuri G; Hedrick AF; Awasthi V; Cowley BD; Gali H
    Nucl Med Biol; 2016 Jan; 43(1):1-5. PubMed ID: 26702780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of Sodium-Glucose Cotransporter 2 with Dapagliflozin in Han: SPRD Rats with Polycystic Kidney Disease.
    Rodriguez D; Kapoor S; Edenhofer I; Segerer S; Riwanto M; Kipar A; Yang M; Mei C; Wüthrich RP
    Kidney Blood Press Res; 2015; 40(6):638-47. PubMed ID: 26698317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased epithelial cell proliferation and abnormal extracellular matrix in rat polycystic kidney disease.
    Ramasubbu K; Gretz N; Bachmann S
    J Am Soc Nephrol; 1998 Jun; 9(6):937-45. PubMed ID: 9621276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.